Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Opalka"'
Autor:
Samuel J. Danishefsky, Meizhen Feng, Hong C. Song, Isaac J. Krauss, Vadim Y. Dudkin, John W. Shiver, Renee Hrin, Joseph G. Joyce, Michael Chastain, Mark T. Esser, David Opalka, Karen M. Grimm, Deborah D. Nahas
Publikováno v:
Proceedings of the National Academy of Sciences. 105:15684-15689
The conserved oligomannose epitope, Man9GlcNAc2, recognized by the broadly neutralizing human mAb 2G12 is an attractive prophylactic vaccine candidate for the prevention of HIV-1 infection. We recently reported total chemical synthesis of a series of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a11654bacf397ead1d4b4e28d84c33
https://doi.org/10.1073/pnas.0807837105
https://doi.org/10.1073/pnas.0807837105
Autor:
Richard Gesser, Richard M. Haupt, Tina Green, Mark T. Esser, Katie Matys, Alfred J. Saah, David Opalka, Paul Bojczuk, Frank J. Dutko
Publikováno v:
Clinical and vaccine immunology : CVI. 17(5)
A multiplexed human papillomavirus (HPV) immunoassay has been developed for the detection of human IgG antibodies to HPV type 6, 11, 16, 18, 31, 33, 45, 52, and 58 virus-like particle (VLP) types in serum following natural infection or immunization w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92731565d08ab23c4d58916dba4734bc
https://pubmed.ncbi.nlm.nih.gov/20237197
https://pubmed.ncbi.nlm.nih.gov/20237197
Autor:
David Radley, David Opalka, Joseph M. Antonello, Tina Green, Katie Matys, Daniel Sikkema, Eliav Barr, Mark T. Esser
Publikováno v:
The FASEB Journal. 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66f70e958918bbd6f8f74746712137d1
https://doi.org/10.1096/fasebj.22.1_supplement.859.14
https://doi.org/10.1096/fasebj.22.1_supplement.859.14
Autor:
Adam C. Finnefrock, Xiaomei Liu, Danilo R. Casimiro, David Opalka, Jon H. Condra, John W. Shiver
Publikováno v:
AIDS research and human retroviruses. 23(10)
One of the greatest challenges in HIV vaccine development is accommodating the worldwide sequence diversity of the HIV-1 virus. To understand how viral sequence diversity may affect the potential breadth of HIV-1 vaccines designed to elicit antiviral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::159ad6aa928fe0b357b5c35a8fea5088
https://pubmed.ncbi.nlm.nih.gov/17961117
https://pubmed.ncbi.nlm.nih.gov/17961117
Autor:
Emilio A. Emini, Elisabetta Bianchi, David Bramhill, William Magilton, Gennaro Ciliberto, James C. Cook, Michael W. Miller, Mark T. Esser, John W. Shiver, Antonello Pessi, Joseph G. Joyce, William A. Schleif, Renee Danzeisen, David Opalka, Michael McElhaugh, Debra M Eckert, Romas Geleziunas
Publikováno v:
Journal of immunological methods. 287(1-2)
A fluorescence-based, multiplexed, antibody-binding and mapping assay was developed to characterize antibody responses in HIV-1-infected individuals to the ectodomain of the HIV-1 gp41 envelope glycoprotein. The antigen panel included intact recombin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50928d4dc0b10bb1c6f92b7516983b2
https://pubmed.ncbi.nlm.nih.gov/15099755
https://pubmed.ncbi.nlm.nih.gov/15099755
Autor:
Kathrin U. Jansen, Stefani A. MacMullen, Charles E. Lachman, Narendra Chirmule, David Opalka, Mark T. Esser, Judith F. Smith
Several different methods have been developed to quantitate neutralizing antibody responses to human papillomaviruses (HPVs), including in vivo neutralization assays, in vitro pseudoneutralization assays, competitive radioimmunoassays (cRIAs), and en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf50bebbe95371364bd39645bf5904b
https://europepmc.org/articles/PMC145272/
https://europepmc.org/articles/PMC145272/
